Brian A. Markison's most recent trade in Lantheus Holdings Inc was a trade of 70,909 Common Stock done . Disclosure was reported to the exchange on March 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lantheus Holdings Inc | Brian A. Markison | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 70,909 | 232,420 (0%) | 0% | 0 | Common Stock | |
| Lantheus Holdings Inc | Brian A. Markison | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 41,347 | 41,347 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Brian A. Markison | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.86 per share. | 03 Mar 2025 | 8,637 | 161,511 (0%) | 0% | 94.9 | 819,306 | Common Stock |
| Lantheus Holdings Inc | Markison Brian A. | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.00 per share. | 19 Dec 2024 | 16,666 | 185,594 (0%) | 0% | 6 | 99,996 | Common Stock |
| Lantheus Holdings Inc | A. Markison Brian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2024 | 16,666 | 0 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Markison Brian A. | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2024 | 16,102 | 0 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | A. Markison Brian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.42 per share. | 19 Dec 2024 | 16,102 | 168,928 (0%) | 0% | 12.4 | 199,987 | Common Stock |
| Lantheus Holdings Inc | A. Markison Brian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.15 per share. | 19 Dec 2024 | 15,446 | 170,148 (0%) | 0% | 91.2 | 1,407,903 | Common Stock |
| Lantheus Holdings Inc | Brian A. Markison | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 131,496 | 152,826 (0%) | 0% | 0 | Common Stock | |
| Lantheus Holdings Inc | Brian A. Markison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 3,798 | 3,798 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Brian A. Markison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 2,012 | 21,330 (0%) | 0% | 0 | Common Stock | |
| Lantheus Holdings Inc | Brian A. Markison | Director | Sale of securities on an exchange or to another person at price $ 81.13 per share. | 27 Mar 2023 | 13,290 | 19,318 (0%) | 0% | 81.1 | 1,078,218 | Common Stock |
| Lantheus Holdings Inc | Brian A. Markison | Director | Sale of securities on an exchange or to another person at price $ 84.10 per share. | 08 Sep 2022 | 23,852 | 46,396 (0%) | 0% | 84.1 | 2,006,044 | Common Stock |
| Lantheus Holdings Inc | Brian A. Markison | Director | Sale of securities on an exchange or to another person at price $ 84.84 per share. | 08 Sep 2022 | 13,788 | 32,608 (0%) | 0% | 84.8 | 1,169,785 | Common Stock |
| Lantheus Holdings Inc | Brian A. Markison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 11,725 | 0 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Brian A. Markison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.06 per share. | 08 Sep 2022 | 11,725 | 74,420 (0%) | 0% | 17.1 | 200,029 | Common Stock |
| Lantheus Holdings Inc | Brian A. Markison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.11 per share. | 08 Sep 2022 | 9,464 | 62,695 (0%) | 0% | 19.1 | 180,857 | Common Stock |
| Lantheus Holdings Inc | Brian A. Markison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 9,464 | 0 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Brian A. Markison | Director | Sale of securities on an exchange or to another person at price $ 83.05 per share. | 08 Sep 2022 | 4,172 | 70,248 (0%) | 0% | 83.0 | 346,464 | Common Stock |
| Lantheus Holdings Inc | Brian A. Markison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 3,263 | 0 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Brian A. Markison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.13 per share. | 08 Sep 2022 | 3,263 | 53,231 (0%) | 0% | 21.1 | 68,947 | Common Stock |
| Lantheus Holdings Inc | Brian A. Markison | Director | Sale of securities on an exchange or to another person at price $ 78.50 per share. | 06 Sep 2022 | 1,693 | 49,968 (0%) | 0% | 78.5 | 132,901 | Common Stock |
| Lantheus Holdings Inc | Brian A. Markison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2022 | 1,693 | 0 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Brian A. Markison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.78 per share. | 06 Sep 2022 | 1,693 | 51,661 (0%) | 0% | 19.8 | 33,488 | Common Stock |
| RVL Pharmaceuticals plc | Brian A. Markison | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 08 Aug 2022 | 850,000 | 2,976,020 (5%) | 1% | 1.6 | 1,317,500 | Ordinary Shares |
| Lantheus Holdings Inc | Brian A. Markison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 4,068 | 4,068 | - | - | Stock Option (right to buy) | |
| RVL Pharmaceuticals plc | Brian A. Markison | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 615,000 | 615,000 | - | - | Share Option (Right to Buy) | |
| Lantheus Holdings Inc | Brian A. Markison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 8,513 | 47,788 (0%) | 0% | 0 | Common Stock | |
| Lantheus Holdings Inc | Brian A. Markison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 2,277 | 39,275 (0%) | 0% | 0 | Common Stock | |
| Lantheus Holdings Inc | Brian A. Markison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 1,354 | 36,998 (0%) | 0% | 0 | Common Stock |